IRIS
ARMENIA, DANIELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.670
AS - Asia 1.120
EU - Europa 800
SA - Sud America 143
AF - Africa 41
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 3
Totale 5.780
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.631
SG - Singapore 528
CN - Cina 259
IT - Italia 239
BR - Brasile 117
HK - Hong Kong 115
RU - Federazione Russa 114
VN - Vietnam 92
DE - Germania 81
SE - Svezia 62
IE - Irlanda 61
FR - Francia 44
GB - Regno Unito 42
FI - Finlandia 30
UA - Ucraina 30
JP - Giappone 24
CA - Canada 21
AT - Austria 19
NL - Olanda 19
IN - India 18
KR - Corea 18
PL - Polonia 13
AR - Argentina 12
IQ - Iraq 12
BE - Belgio 10
ES - Italia 10
ID - Indonesia 10
MX - Messico 10
ZA - Sudafrica 10
BD - Bangladesh 9
CZ - Repubblica Ceca 9
CM - Camerun 6
KE - Kenya 5
TR - Turchia 5
CH - Svizzera 4
IL - Israele 4
IR - Iran 4
CL - Cile 3
CO - Colombia 3
DO - Repubblica Dominicana 3
EG - Egitto 3
MN - Mongolia 3
PH - Filippine 3
RO - Romania 3
TD - Ciad 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AO - Angola 2
AU - Australia 2
BG - Bulgaria 2
DK - Danimarca 2
EC - Ecuador 2
JM - Giamaica 2
KZ - Kazakistan 2
LT - Lituania 2
MA - Marocco 2
MY - Malesia 2
NP - Nepal 2
PE - Perù 2
SA - Arabia Saudita 2
TN - Tunisia 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BJ - Benin 1
BW - Botswana 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
GT - Guatemala 1
ML - Mali 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SC - Seychelles 1
SI - Slovenia 1
SN - Senegal 1
TH - Thailandia 1
UY - Uruguay 1
Totale 5.780
Salva come PNG Salva come JPEG
Città #
Wilmington 835
Houston 649
Woodbridge 500
Singapore 309
Chandler 205
Beijing 173
Ashburn 135
Fairfield 125
Hong Kong 111
San Jose 109
Rome 82
Ann Arbor 77
Seattle 66
Dublin 58
New York 47
Cambridge 45
The Dalles 45
Santa Clara 42
Los Angeles 41
Medford 41
Council Bluffs 39
Munich 32
Hanoi 30
Ho Chi Minh City 27
Tokyo 23
Dallas 21
Helsinki 20
Dearborn 19
São Paulo 19
Lawrence 18
Lauterbourg 17
Creede 16
Milan 16
Orem 16
Moscow 15
Jacksonville 14
Buffalo 13
Nuremberg 13
Chicago 12
London 11
Brussels 10
Colorado Springs 10
North Bergen 10
Florence 9
Montreal 9
San Diego 9
Chennai 8
Jakarta 8
Phoenix 8
Vienna 8
Dong Ket 7
Seoul 7
Stockholm 7
Amsterdam 6
Atlanta 6
Brno 6
Denver 6
Manchester 6
Redondo Beach 6
Boardman 5
Frankfurt am Main 5
Lappeenranta 5
Nairobi 5
Nepi 5
San Francisco 5
Shanghai 5
Warsaw 5
Baghdad 4
Binasco 4
Brooklyn 4
Cagliari 4
Johannesburg 4
Kraków 4
Mumbai 4
Paris 4
Perugia 4
Poplar 4
Redwood City 4
Belo Horizonte 3
Birmingham 3
Boston 3
Brasília 3
Columbus 3
Falmer 3
Genoa 3
Haifa 3
Istanbul 3
Magenta 3
Manitou Springs 3
Menlo Park 3
Mexico City 3
Mülheim 3
N'Djamena 3
Nanjing 3
Olomouc 3
Palo Alto 3
Rio de Janeiro 3
Santo André 3
São Gonçalo 3
Toronto 3
Totale 4.382
Salva come PNG Salva come JPEG
Nome #
Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro 487
Kinetics of hepatitis C virus RNA decay, quasispecies evolution and risk of virological failure during telaprevir-based triple therapy in clinical practice 484
Next-generation sequencing provides an added value in determining drug resistance and viral tropism in Cameroonian HIV-1 vertically infected children 395
Ultradeep sequencing detection of the R263K integrase inhibitor drug resistance mutation 384
Pre-existent NRTI and NNRTI resistance impacts on maintenance of virological suppression in HIV-1-infected patients who switch to a tenofovir/emtricitabine/rilpivirine single-tablet regimen 376
Integrase strand transfer inhibitor-based regimen is related with a limited HIV-1 V3 loop evolution in clinical practice 364
Focus on recently developed assays for detection of resistance/sensitivity to reverse transcriptase inhibitors 307
Resistance detected in PBMCs predicts virological rebound in HIV-1 suppressed patients switching treatment 304
HCV resistance compartmentalization within tumoral and non-tumoral liver in transplanted patients with hepatocellular carcinoma 257
Impact of integrase polymorphisms and minor quasispecies in HIV-1 infected individuals naive or treated with strand-transfer integrase inhibitors: a refined analysis by cloning and 454-pyrosequencing techniques 251
HIV MDR is still a relevant issue despite its dramatic drop over the years 237
Temporal trend of drug-resistance and APOBEC editing in PBMC genotypic resistance tests from HIV-1 infected virologically suppressed individuals 136
Baseline integrase drug resistance mutations and conserved regions across HIV-1 clades in Cameroon: implications for transition to dolutegravir in resource-limited settings 132
CMV seroprevalence and coronary CMV-DNA detection in immunocompetent patients with heart diseases 131
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21 123
Detection of Gag C-terminal mutations among HIV-1 non-B subtypes in a subset of Cameroonian patients 121
High performance of integrase genotyping on diverse HIV-1 clades circulating in Cameroon: toward a successful transition to dolutegravir-based regimens in low and middle-income countries 119
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 111
Viral resistance burden and APOBEC editing correlate with virological response in heavily treatment-experienced people living with multi-drug resistant HIV 110
Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry 108
A high genetic heterogeneity in HBsAg can affect immunogenicity in acute hepatitis B infection. 107
Genotypic HIV-1 tropism determination might help to identify people with exhausted treatment options and advanced disease 102
Bictegravir/emtricitabine/tenofovir alafenamide ensures high rates of virological suppression maintenance despite previous resistance in PLWH who optimize treatment in clinical practice 100
Genetic signatures specifically clustered in immune active HBsAg regions correlate with immunosuppression-driven HBV reactivation: An extensive analysis of HBV genome. 99
Genotypic Resistance Testing of HIV-1 DNA in Peripheral Blood Mononuclear Cells 97
Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study 92
Evaluation of HIV-1 capsid genetic variability and lenacapavir (GS-6207) drug resistance-associated mutations according to viral clades among drug-naive individuals 90
Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings 80
null 74
Virological response and resistance profile in highly treatment-experienced HIV-1-infected patients switching to dolutegravir plus boosted darunavir in clinical practice 63
Role of low-frequency integrase strand transfer inhibitor resistance mutations on virological outcomes in antiretroviral therapy-naïve individuals initiating second-generation integrase inhibitors 62
Poor CD4/CD8 ratio recovery in HBcAb-positive HIV patients with worse immune status is associated with significantly higher CD8 cell numbers 36
Evaluation of HIV-1 transmitted drug-resistance among subtypes circulating from 2022 to 2024 in Italy: a refined analysis through next-generation sequencing 14
Confirmed virological failure following enhanced adherence counseling among virally unsuppressed children and adolescents on dolutegravir-based versus other regimens: Evidence from a cohort analysis in Cameroon 12
Persistence of CXCR4-tropic virus in people living with four-class drug-resistant HIV and its clinical impact in the modern antiretroviral era 11
Tenofovir and Doravirine Are Potential Reverse-Transcriptase Analogs in Combination with the New Reverse-Transcriptase Translocation Inhibitor (Islatravir) Among Treatment-Experienced Patients in Cameroon: Designing Future Treatment Strategies for Low- and Middle-Income Countries 9
Totale 5.985
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.048
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.048
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202162 0 0 0 0 0 0 0 0 0 28 18 16
2021/2022298 27 16 18 16 4 12 18 5 83 24 14 61
2022/2023519 44 62 51 55 48 73 22 76 44 22 11 11
2023/2024173 27 2 8 12 14 31 12 18 6 15 5 23
2024/2025979 30 154 112 55 38 41 117 48 103 69 51 161
2025/20261.443 156 51 133 183 156 60 219 154 171 160 0 0
Totale 5.985